DC
Therapeutic Areas
Anteris Technologies Pipeline
| Drug | Indication | Phase |
|---|---|---|
| DurAVR™ THV | Severe Aortic Stenosis | Pivotal |
| DurAVR™ THV (Small Annuli) | Severe Aortic Stenosis in Small Aortic Annuli | Early Feasibility / Post-Market |
Leadership Team at Anteris Technologies
WP
Wayne Paterson
Vice Chairman and Chief Executive Officer
DM
Dr. Michael Reardon
Professor of Cardiothoracic Surgery (KOL)
DR
Dr. Rebecca T. Hahn
Director of Interventional Echocardiography (KOL)
DJ
Dr. Jeffrey Popma
Presenting Investigator (KOL)
PO
Prof. Ole De Backer
Key Opinion Leader / Investigator
PN
Prof. Nicolas Van Mieghem
Key Opinion Leader / Investigator
DR
Dr. Rishi Puri
Principal Investigator (KOL)